JPRN-jRCT2080224985CompletedPhase 2
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 400
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 40age old to <= 85age old (—)
- Sex
- All
Inclusion Criteria
- •Patient meets American College of Rheumatology Criteria (ACR) for Osteoarthritis of the knee
Exclusion Criteria
- •*Patient has renal, hepatic, cardiac, pancreatic, or metabolic diseases or hematologic abnormality.
- •*Patient is on a current treatment for malignancy or has a history of malignancy within the past 5 years.
- •*Patient who are pregnant or may be pregnant, who wants to be pregnant during the trial period, patients who are nursing. Patient who cannot agree on proper contraception in the patient or the patient's female partner is a pregnant woman.
Investigators
Similar Trials
Not yet recruiting
Phase 2
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the knee.Pain due to osteoarthritisJPRN-jRCT2031230469Kudo Katsuyasu400
Completed
Phase 2
Randomized, Double-Blind Study of AK1830 in Patients with low back paiow back painJPRN-jRCT2080225352Asahi Kasei Pharma Corporation400
Completed
Phase 2
Follow ups of patients in AK1830 Phase II Studiesosteoarthritis, chronic lumbar painJPRN-jRCT2031210566Kudo Katsuyasu10
Completed
Phase 1
Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)JPRN-jRCT2051200119Shimizu Tomohito20
Completed
Phase 1
Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)JPRN-jRCT2051200123Shimizu Tomohito40